Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2017 1
2018 1
2019 3
2020 3
2021 4
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

15 results

Results by year

Filters applied: . Clear all
Page 1
Hyperlipidaemia and cardioprotection: Animal models for translational studies.
Andreadou I, Schulz R, Badimon L, Adameová A, Kleinbongard P, Lecour S, Nikolaou PE, Falcão-Pires I, Vilahur G, Woudberg N, Heusch G, Ferdinandy P. Andreadou I, et al. Among authors: nikolaou pe. Br J Pharmacol. 2020 Dec;177(23):5287-5311. doi: 10.1111/bph.14931. Epub 2020 Jan 17. Br J Pharmacol. 2020. PMID: 31769007 Free PMC article. Review.
Hydrolytic Activity of Mitochondrial F1FO-ATP Synthase as a Target for Myocardial Ischemia-Reperfusion Injury: Discovery and In Vitro and In Vivo Evaluation of Novel Inhibitors.
Nikolaou PE, Lambrinidis G, Georgiou M, Karagiannis D, Efentakis P, Bessis-Lazarou P, Founta K, Kampoukos S, Konstantin V, Palmeira CM, Davidson SM, Lougiakis N, Marakos P, Pouli N, Mikros E, Andreadou I. Nikolaou PE, et al. J Med Chem. 2023 Nov 23;66(22):15115-15140. doi: 10.1021/acs.jmedchem.3c01048. Epub 2023 Nov 9. J Med Chem. 2023. PMID: 37943012
Cardioprotection by selective SGLT-2 inhibitors in a non-diabetic mouse model of myocardial ischemia/reperfusion injury: a class or a drug effect?
Nikolaou PE, Mylonas N, Makridakis M, Makrecka-Kuka M, Iliou A, Zerikiotis S, Efentakis P, Kampoukos S, Kostomitsopoulos N, Vilskersts R, Ikonomidis I, Lambadiari V, Zuurbier CJ, Latosinska A, Vlahou A, Dimitriadis G, Iliodromitis EK, Andreadou I. Nikolaou PE, et al. Basic Res Cardiol. 2022 May 17;117(1):27. doi: 10.1007/s00395-022-00934-7. Basic Res Cardiol. 2022. PMID: 35581445
Reactive Vasodilation Predicts Mortality in Primary Systemic Light-Chain Amyloidosis.
Stamatelopoulos K, Georgiopoulos G, Athanasouli F, Nikolaou PE, Lykka M, Roussou M, Gavriatopoulou M, Laina A, Trakada G, Charakida M, Delialis D, Petropoulos I, Pamboukas C, Manios E, Karakitsou M, Papamichael C, Gatsiou A, Lambrinoudaki I, Terpos E, Stellos K, Andreadou I, Dimopoulos MA, Kastritis E. Stamatelopoulos K, et al. Among authors: nikolaou pe. Circ Res. 2019 Sep 27;125(8):744-758. doi: 10.1161/CIRCRESAHA.119.314862. Epub 2019 Aug 12. Circ Res. 2019. PMID: 31401949 Free PMC article.
Mineralocorticoid Receptor Pathway Is a Key Mediator of Carfilzomib-induced Nephrotoxicity: Preventive Role of Eplerenone.
Efentakis P, Lamprou S, Makridakis M, Barla I, Nikolaou PE, Christodoulou A, Dimitriou C, Kostomitsopoulos N, Ntanasis-Stathopoulos I, Theochari I, Gavriatopoulou M, Gakiopoulou H, Tasouli A, Vlahou A, Gikas E, Thomaidis N, Dimopoulos MA, Terpos E, Andreadou I. Efentakis P, et al. Among authors: nikolaou pe. Hemasphere. 2022 Oct 18;6(11):e791. doi: 10.1097/HS9.0000000000000791. eCollection 2022 Nov. Hemasphere. 2022. PMID: 36285072 Free PMC article.
Molecular mechanisms of carfilzomib-induced cardiotoxicity in mice and the emerging cardioprotective role of metformin.
Efentakis P, Kremastiotis G, Varela A, Nikolaou PE, Papanagnou ED, Davos CH, Tsoumani M, Agrogiannis G, Konstantinidou A, Kastritis E, Kanaki Z, Iliodromitis EK, Klinakis A, Dimopoulos MA, Trougakos IP, Andreadou I, Terpos E. Efentakis P, et al. Among authors: nikolaou pe. Blood. 2019 Feb 14;133(7):710-723. doi: 10.1182/blood-2018-06-858415. Epub 2018 Nov 27. Blood. 2019. PMID: 30482794 Free article.
Acute administration of the olive constituent, oleuropein, combined with ischemic postconditioning increases myocardial protection by modulating oxidative defense.
Tsoumani M, Georgoulis A, Nikolaou PE, Kostopoulos IV, Dermintzoglou T, Papatheodorou I, Zoga A, Efentakis P, Konstantinou M, Gikas E, Kostomitsopoulos N, Papapetropoulos A, Lazou A, Skaltsounis AL, Hausenloy DJ, Tsitsilonis O, Tseti I, Di Lisa F, Iliodromitis EK, Andreadou I. Tsoumani M, et al. Among authors: nikolaou pe. Free Radic Biol Med. 2021 Apr;166:18-32. doi: 10.1016/j.freeradbiomed.2021.02.011. Epub 2021 Feb 12. Free Radic Biol Med. 2021. PMID: 33582227
15 results